Market Cap

Eagle Pharmaceuticals, Inc. Market Capitalization:

$71.3 Million

USD as of July 1, 2024

business Eagle Pharmaceuticals, Inc. Company Profile

Eagle Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: EGRX

Market Capitalization History of Eagle Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Eagle Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $66.6 M -84.10%
Jan. 1, 2023 $418.9 M -28.47%
Jan. 1, 2022 $585.7 M -1.56%
Jan. 1, 2021 $595.0 M -13.29%
Jan. 1, 2020 $686.1 M 27.35%
Jan. 1, 2019 $538.8 M -29.30%
Jan. 1, 2018 $762.0 M -13.64%
Jan. 1, 2017 $882.3 M -3.74%
Jan. 1, 2016 $916.6 M 270.43%
Jan. 1, 2015 $247.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Eagle Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Eagle Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: EGRX

Stock: FSX: 1000000

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.